Sean Tucker - Jun 16, 2021 Form 4 Insider Report for Vaxart, Inc. (VXRT)

Role
SVP, Chief Scientific Officer
Signature
/s/ Sean N. Tucker
Stock symbol
VXRT
Transactions as of
Jun 16, 2021
Transactions value $
$0
Form type
4
Date filed
6/17/2021, 04:23 PM
Next filing
Aug 11, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VXRT Stock Option (right to buy) Award $0 +100K $0.00 100K Jun 16, 2021 Common stock 100K $6.27 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option grant was approved by the board of directors of Vaxart, Inc. on March 25, 2021, subject to stockholder approval of an amendment to the Vaxart, Inc. 2019 Equity Incentive Plan, under which the stock option was granted. Vaxart, Inc.'s stockholders approved the plan amendment on June 16, 2021.
F2 The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 25, 2022, the first anniversary of the date that the grant was approved by the board of directors, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 25, 2025.